Meeting
2018 ASCO Annual Meeting
Association of CDKN2A gene alteration with high expression of PD-L1.
Authors
Yan Zhang
Department of Cancer Biology, Mayo Clinic, Jacksonville, FL
Yan Zhang , Julian A. Marin-Acevedo , Abdel Ghani Azzouqa , Rami Manochakian , Yanyan Lou
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 36, 2018 (suppl; abstr 9102)
DOI
10.1200/JCO.2018.36.15_suppl.9102
Abstract #
9102
Poster Bd #
425
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates
Poster
2021 ASCO Annual Meeting
Prevalence of hyperprogressive disease (HPD) mutations and correlations to immune-related biomarkers in a large pan-cancer Chinese cohort.
First Author: Shengli Yang
Poster
2020 ASCO Virtual Scientific Program
Clinically aggressive malignancies associated with STK11 germline mutations (STK11GCa): A comprehensive genomic profiling (CGP) study.
First Author: Ethan Sokol
Poster
2019 ASCO Annual Meeting
Profiling of 3,634 cholangiocarcinomas (CCA) to identify genomic alterations (GA), tumor mutational burden (TMB), and genomic loss of heterozygosity (gLOH).
First Author: Milind M. Javle